Both in Pharmaceuticals
BioVie vs Lipocine
Over the past year BIVI returned −21.5% and LPCN returned −45.1%; their daily moves had a correlation of 0.03.
BIVI −21.5% LPCN −45.1%Growth of $1, one year, split-adjusted
| Metric | BIVI | LPCN |
|---|---|---|
| Price | $1.46 | $1.51 |
| Market cap | $12.7M | $12.4M |
| Today | +1.39% | +3.42% |
| 1 month | −5.2% | −30.1% |
| 6 months | −7.6% | −34.1% |
| Year to date | +25.9% | −81.2% |
| 1 year | −22.8% | −46.5% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 9.9× |
| Net cash | $9.0M | $23.3M |
| Dividend yield | — | — |
| Volatility (60d) | 182.0% | 56.7% |
| Short % of float | 7.8% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).